Pfizer (PFE)
(Delayed Data from NYSE)
$29.74 USD
-0.69 (-2.27%)
Updated Aug 5, 2024 04:01 PM ET
After-Market: $29.87 +0.13 (0.44%) 7:58 PM ET
2-Buy of 5 2
A Value F Growth A Momentum C VGM
Price, Consensus and EPS Surprise
PFE 29.74 -0.69(-2.27%)
Will PFE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PFE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PFE
Volatility Spikes: 3 Low Beta Stocks to Buy
Novavax (NVAX) Stock Before Q2 Earnings: To Buy or Not to Buy?
PFE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Pfizer (PFE) Run Higher on Rising Earnings Estimates?
PFE vs. NVO: Which Stock Is the Better Value Option?
Are Investors Undervaluing Pfizer (PFE) Right Now?
Other News for PFE
Genmab stock slides 7% as BioNTech ends acasunlimab collaboration
Pfizer: Tracking Well Above The Industry
19 out of 21 Healthcare companies topped profit estimates this week: Earnings Scorecard
Over 80% of companies that reported earnings this week beat profit estimates - Earnings Scorecard
About half of US state AGs went on France trip sponsored by group with lobbyist and corporate funds